Payment overview · 2025
General Payments
$22.03
1 reported records · 1 companies
Healthcare provider profile · identity verified
Dani Mathew, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · DUNEDIN, FL · NPI 1679766414
Verified facts
What the public records show
CMS Open Payments records show Dani Mathew, M.D. received $22.03 in general payments during 2025 across 1 reported records.
Novo Nordisk Inc accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Ozempic.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 90 claims for Ozempic by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $22.03 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $22.03 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $22.03 | 1 | 2025 |
Source payment records
|
|||||
| Rybelsus Normalized: rybelsus |
Drug | Novo Nordisk Inc | $22.03 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| Ozempic ozempic |
2025 | Ozempic | 2024 | 90 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
90 | 18 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 985 | 219 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 774 | 216 |
| Levothyroxine Sodium | Levothyroxine Sodium | 738 | 172 |
| Amlodipine Besylate | Amlodipine Besylate | 647 | 173 |
| Eliquis | Apixaban | 531 | 69 |
| Losartan Potassium | Losartan Potassium | 404 | 100 |
| Gabapentin | Gabapentin | 389 | 80 |
| Lisinopril | Lisinopril | 378 | 97 |
| Pantoprazole Sodium | Pantoprazole Sodium | 364 | 98 |
| Tamsulosin Hcl | Tamsulosin Hcl | 307 | 67 |
| Trazodone Hcl | Trazodone Hcl | 258 | 67 |
| Clopidogrel | Clopidogrel Bisulfate | 255 | 53 |
| Potassium Chloride | Potassium Chloride | 253 | 69 |
| Metformin Hcl | Metformin Hcl | 251 | 63 |
| Carvedilol | Carvedilol | 242 | 46 |
| Omeprazole | Omeprazole | 242 | 70 |
| Furosemide | Furosemide | 238 | 67 |
| Metoprolol Tartrate | Metoprolol Tartrate | 227 | 57 |
| Donepezil Hcl | Donepezil Hcl | 224 | 48 |
| Hydrochlorothiazide | Hydrochlorothiazide | 222 | 55 |
| Memantine Hcl | Memantine Hcl | 212 | 42 |
| Simvastatin | Simvastatin | 211 | 56 |
| Spironolactone | Spironolactone | 199 | 43 |
| Sertraline Hcl | Sertraline Hcl | 195 | 61 |
| Escitalopram Oxalate | Escitalopram Oxalate | 194 | 44 |
| Telmisartan | Telmisartan | 191 | 53 |
| Metoprolol Succinate | Metoprolol Succinate | 176 | 50 |
| Mirtazapine | Mirtazapine | 173 | 43 |
| Alprazolam | Alprazolam | 170 | 34 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 157 | 27 |
| Xarelto | Rivaroxaban | 153 | 24 |
| Finasteride | Finasteride | 147 | 28 |
| Tramadol Hcl | Tramadol Hcl | 146 | 27 |
| Prednisone | Prednisone | 144 | 76 |
| Allopurinol | Allopurinol | 139 | 35 |
| Montelukast Sodium | Montelukast Sodium | 135 | 33 |
| Metformin Hcl Er | Metformin Hcl | 134 | 45 |
| Myrbetriq | Mirabegron | 121 | 14 |
| Warfarin Sodium | Warfarin Sodium | 121 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 116 | 33 |
| Januvia | Sitagliptin Phosphate | 114 | 21 |
| Divalproex Sodium | Divalproex Sodium | 111 | 27 |
| Jardiance | Empagliflozin | 111 | 19 |
| Pravastatin Sodium | Pravastatin Sodium | 107 | 28 |
| Duloxetine Hcl | Duloxetine Hcl | 98 | 22 |
| Quetiapine Fumarate | Quetiapine Fumarate | 93 | 27 |
| Lorazepam | Lorazepam | 92 | 14 |
| Ramipril | Ramipril | 91 | 19 |
| Ozempic | Semaglutide | 90 | 18 |
| Hydralazine Hcl | Hydralazine Hcl | 88 | 26 |
| Lovastatin | Lovastatin | 87 | 18 |
| Ondansetron Hcl | Ondansetron Hcl | 85 | 27 |
| Buspirone Hcl | Buspirone Hcl | 79 | 26 |
| Fluticasone Propionate | Fluticasone Propionate | 75 | 24 |
| Ibandronate Sodium | Ibandronate Sodium | 74 | 25 |
| Bumetanide | Bumetanide | 73 | 21 |
| Famotidine | Famotidine | 72 | 27 |
| Latanoprost | Latanoprost | 72 | 18 |
| Zolpidem Tartrate | Zolpidem Tartrate | 72 | 16 |
| Fluoxetine Hcl | Fluoxetine Hcl | 70 | 19 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 70 | 23 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 68 | 15 |
| Lactulose | Lactulose | 68 | 21 |
| Midodrine Hcl | Midodrine Hcl | 67 | 16 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 66 | 27 |
| Celecoxib | Celecoxib | 65 | 18 |
| Meloxicam | Meloxicam | 65 | 18 |
| Ezetimibe | Ezetimibe | 63 | 17 |
| Atenolol | Atenolol | 61 | 17 |
| Baclofen | Baclofen | 59 | 20 |
| Sucralfate | Sucralfate | 59 | 12 |
| Azithromycin | Azithromycin | 58 | 49 |
| Diclofenac Sodium | Diclofenac Sodium | 58 | 20 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 58 | 14 |
| Levetiracetam | Levetiracetam | 54 | 15 |
| Symbicort | Budesonide/Formoterol Fumarate | 54 | 11 |
| Levemir Flexpen | Insulin Detemir | 53 | suppressed |
| Bupropion Xl | Bupropion Hcl | 52 | 19 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 51 | 14 |
| Synthroid | Levothyroxine Sodium | 51 | 14 |
| Amiodarone Hcl | Amiodarone Hcl | 50 | 17 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 49 | 11 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 49 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 46 | 36 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 46 | 11 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 46 | suppressed |
| Valsartan | Valsartan | 45 | 12 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 44 | 17 |
| Citalopram Hbr | Citalopram Hydrobromide | 43 | suppressed |
| Clonazepam | Clonazepam | 42 | 12 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 42 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 41 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 41 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 41 | 12 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 40 | 33 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 40 | 12 |
| Ceftriaxone | Ceftriaxone Sodium | 39 | 26 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 39 | suppressed |
| Aripiprazole | Aripiprazole | 38 | suppressed |
| Brilinta | Ticagrelor | 37 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 37 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 36 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 36 | 13 |
| Doxycycline Hyclate | Doxycycline Hyclate | 35 | 28 |
| Insulin Aspart Flexpen | Insulin Aspart | 35 | suppressed |
| Primidone | Primidone | 35 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 34 | suppressed |
| Fenofibrate | Fenofibrate | 34 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 34 | 13 |
| Valacyclovir | Valacyclovir Hcl | 34 | suppressed |
| Acyclovir | Acyclovir | 33 | 11 |
| Brimonidine Tartrate | Brimonidine Tartrate | 33 | suppressed |
| Ketoconazole | Ketoconazole | 33 | 22 |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 33 | 11 |
| Tradjenta | Linagliptin | 33 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 33 | 18 |
| Acetazolamide | Acetazolamide | 32 | suppressed |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 32 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 32 | suppressed |
| Risperidone | Risperidone | 31 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 30 | 11 |
| Bupropion Hcl Sr | Bupropion Hcl | 29 | suppressed |
| Ibuprofen | Ibuprofen | 29 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 29 | suppressed |
| Folic Acid | Folic Acid | 28 | suppressed |
| Methotrexate | Methotrexate Sodium | 27 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 27 | suppressed |
| Cefdinir | Cefdinir | 26 | 17 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 26 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 26 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 26 | 23 |
| Tizanidine Hcl | Tizanidine Hcl | 26 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 25 | 11 |
| Calcitriol | Calcitriol | 25 | suppressed |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 25 | suppressed |
| Fluconazole | Fluconazole | 25 | 12 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 25 | suppressed |
| Misoprostol | Misoprostol | 24 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 24 | 18 |
| Amoxicillin | Amoxicillin | 23 | 12 |
| Cephalexin | Cephalexin | 23 | 11 |
| Temazepam | Temazepam | 23 | suppressed |
| Glimepiride | Glimepiride | 22 | suppressed |
| Glipizide | Glipizide | 22 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 21 | suppressed |
| Methocarbamol | Methocarbamol | 21 | suppressed |
| Nitroglycerin | Nitroglycerin | 21 | 12 |
| Tresiba Flextouch U-100 | Insulin Degludec | 21 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 21 | suppressed |
| Chlorthalidone | Chlorthalidone | 20 | suppressed |
| Novolin 70-30 Flexpen | Insulin Nph Hum/Reg Insulin Hm | 20 | suppressed |
| Nystatin | Nystatin | 20 | 13 |
| Advair Hfa | Fluticasone Propion/Salmeterol | 19 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 19 | suppressed |
| Verapamil Er | Verapamil Hcl | 19 | suppressed |
| Alogliptin | Alogliptin Benzoate | 18 | suppressed |
| Belsomra | Suvorexant | 18 | suppressed |
| Digoxin | Digoxin | 18 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 18 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 18 | suppressed |
| Gemfibrozil | Gemfibrozil | 18 | suppressed |
| Novolog Flexpen | Insulin Aspart | 18 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 18 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 17 | 11 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 17 | suppressed |
| Dutasteride | Dutasteride | 17 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 17 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 17 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 17 | suppressed |
| Pregabalin | Pregabalin | 17 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 17 | 13 |
| Spiriva Respimat | Tiotropium Bromide | 17 | suppressed |
| Sulfasalazine | Sulfasalazine | 17 | suppressed |
| Torsemide | Torsemide | 17 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 16 | suppressed |
| Diazepam | Diazepam | 16 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 16 | suppressed |
| Levofloxacin | Levofloxacin | 16 | 11 |
| Retacrit | Epoetin Alfa-Epbx | 16 | suppressed |
| Risedronate Sodium | Risedronate Sodium | 16 | suppressed |
| Estradiol | Estradiol | 15 | suppressed |
| Mupirocin | Mupirocin | 15 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 14 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 14 | suppressed |
| Lubiprostone | Lubiprostone | 14 | suppressed |
| Mounjaro | Tirzepatide | 14 | suppressed |
| Nifedipine Er | Nifedipine | 14 | suppressed |
| Steglatro | Ertugliflozin Pidolate | 14 | suppressed |
| Trulicity | Dulaglutide | 14 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 13 | suppressed |
| Clonidine | Clonidine | 13 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 13 | suppressed |
| Febuxostat | Febuxostat | 13 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 13 | suppressed |
| Leflunomide | Leflunomide | 13 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl/Pf | 13 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 13 | suppressed |
| Livalo | Pitavastatin Calcium | 13 | suppressed |
| Methylprednisolone | Methylprednisolone | 13 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 13 | suppressed |
| Metronidazole | Metronidazole | 13 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 13 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 13 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 12 | suppressed |
| Dulera | Mometasone/Formoterol | 12 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 12 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 12 | suppressed |
| Insulin Lispro | Insulin Lispro | 12 | suppressed |
| Praluent Pen | Alirocumab | 12 | suppressed |
| Quviviq | Daridorexant Hcl | 12 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 12 | suppressed |
| Trospium Chloride | Trospium Chloride | 12 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 11 | suppressed |
| Clozapine | Clozapine | 11 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 11 | suppressed |
| Dexamethasone | Dexamethasone | 11 | suppressed |
| Dextrose In Water | Dextrose 5 % In Water | 11 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 11 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 11 | suppressed |
| Ertapenem | Ertapenem Sodium | 11 | suppressed |
| Humalog | Insulin Lispro | 11 | suppressed |
| Irbesartan | Irbesartan | 11 | suppressed |
| Lamotrigine | Lamotrigine | 11 | suppressed |
| Levemir | Insulin Detemir | 11 | suppressed |
| Topiramate | Topiramate | 11 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 11 | suppressed |
| Ursodiol | Ursodiol | 11 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $22.03 · 1 records | Novo Nordisk Inc | Ozempic, Rybelsus | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Ozempic play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Novo Nordisk Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error